Page last updated: 2024-09-03

dioscin and Laryngeal Neoplasms

dioscin has been researched along with Laryngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, X; Peng, J; Qi, Y; Si, L; Wang, C; Xu, L; Xu, Y; Yin, L; Zheng, L	1

Other Studies

1 other study(ies) available for dioscin and Laryngeal Neoplasms

Article	Year
Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and MAPK-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion. European journal of pharmacology, 2016, Mar-05, Volume: 774 Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cytochromes c; Diosgenin; DNA Damage; Humans; Laryngeal Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitochondria; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Protein Kinase Inhibitors; Reactive Oxygen Species	2016

Article

Year

Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and MAPK-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion.

European journal of pharmacology, 2016, Mar-05, Volume: 774

Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cytochromes c; Diosgenin; DNA Damage; Humans; Laryngeal Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitochondria; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Protein Kinase Inhibitors; Reactive Oxygen Species

2016